Wells Fargo Starts Mednax (MD) at Market Perform

Wells Fargo initiated coverage on Mednax (NYSE: MD) with a Market Perform rating and a price target of $92.00. Analyst Gary Lieberman thinks solid fundamentals are already reflected in the stock's price.

"We believe that the company is poised to benefit from a rebound in a cyclically low birth rate and also incrementally benefit in 2013-14 from Medicaid Parity which we estimate could add $0.28-0.47 of EPS. However, we think these favorable fundamentals are largely reflected in shares of Mednax," said analyst Lieberman.

For an analyst ratings summary and ratings history on Mednax click here. For more ratings news on Mednax click here.

Shares of Mednax closed at $92.25 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Citi Upgrades United Microelectronics Corp (2303:TT) (UMC) to Buy 'with limited downside'
• SL Green Realty (SLG) PT Lowered to $45 at Jefferies
• Boston Scientific (BSX) PT Raised to $83 at Stifel